Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Ronald S. Duman, George K. Aghajanian, Gerard Sanacora, et al.
Nature Medicine (2016) Vol. 22, Iss. 3, pp. 238-249
Open Access | Times Cited: 1347

Showing 1-25 of 1347 citing articles:

NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos, Ruin Moaddel, Patrick J. Morris, et al.
Nature (2016) Vol. 533, Iss. 7604, pp. 481-486
Open Access | Times Cited: 1375
Mechanisms of ketamine action as an antidepressant
Panos Zanos, Todd D. Gould
Molecular Psychiatry (2018) Vol. 23, Iss. 4, pp. 801-811
Open Access | Times Cited: 893
Psychedelics Promote Structural and Functional Neural Plasticity
Calvin Ly, Alexandra C. Greb, Lindsay P. Cameron, et al.
Cell Reports (2018) Vol. 23, Iss. 11, pp. 3170-3182
Open Access | Times Cited: 816
Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments
Ronald S. Duman, Gerard Sanacora, John H. Krystal
Neuron (2019) Vol. 102, Iss. 1, pp. 75-90
Open Access | Times Cited: 773
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
Vanina Popova, Ella Daly, Madhukar H. Trivedi, et al.
American Journal of Psychiatry (2019) Vol. 176, Iss. 6, pp. 428-438
Open Access | Times Cited: 710
The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain
Jiyao Sheng, Liu Shui, Yicun Wang, et al.
Neural Plasticity (2017) Vol. 2017, pp. 1-10
Open Access | Times Cited: 630
Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
Carla M. Canuso, Jaskaran Singh, Maggie Fedgchin, et al.
American Journal of Psychiatry (2018) Vol. 175, Iss. 7, pp. 620-630
Open Access | Times Cited: 586
Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
Ella Daly, Jaskaran Singh, Maggie Fedgchin, et al.
JAMA Psychiatry (2017) Vol. 75, Iss. 2, pp. 139-139
Open Access | Times Cited: 562
Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation
R. N. Moda-Sava, Mitchell H. Murdock, Puja K. Parekh, et al.
Science (2019) Vol. 364, Iss. 6436
Open Access | Times Cited: 534
The Role of Neural Plasticity in Depression: From Hippocampus to Prefrontal Cortex
Wei Liu, Tongtong Ge, Yashu Leng, et al.
Neural Plasticity (2017) Vol. 2017, pp. 1-11
Open Access | Times Cited: 532
How do antidepressants work? New perspectives for refining future treatment approaches
Catherine J. Harmer, Ronald S. Duman, Philip J. Cowen
The Lancet Psychiatry (2017) Vol. 4, Iss. 5, pp. 409-418
Open Access | Times Cited: 501
Glutamatergic Signaling in the Central Nervous System: Ionotropic and Metabotropic Receptors in Concert
Andreas Reiner, Joshua Levitz
Neuron (2018) Vol. 98, Iss. 6, pp. 1080-1098
Open Access | Times Cited: 498
Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model
Rebecca B. Price, Ronald S. Duman
Molecular Psychiatry (2019) Vol. 25, Iss. 3, pp. 530-543
Open Access | Times Cited: 475
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
Roger S. McIntyre, Joshua D. Rosenblat, Charles B. Nemeroff, et al.
American Journal of Psychiatry (2021) Vol. 178, Iss. 5, pp. 383-399
Open Access | Times Cited: 468
Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders
Ebrahim Haroon, Andrew H. Miller, Gerard Sanacora
Neuropsychopharmacology (2016) Vol. 42, Iss. 1, pp. 193-215
Open Access | Times Cited: 444
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
Nolan Williams, Boris D. Heifets, Christine Blasey, et al.
American Journal of Psychiatry (2018) Vol. 175, Iss. 12, pp. 1205-1215
Open Access | Times Cited: 416
Targeting glutamate signalling in depression: progress and prospects
James W. Murrough, Chadi G. Abdallah, Sanjay J. Mathew
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 7, pp. 472-486
Closed Access | Times Cited: 411
Single-nucleus transcriptomics of the prefrontal cortex in major depressive disorder implicates oligodendrocyte precursor cells and excitatory neurons
Corina Nagy, Malosree Maitra, Arnaud Tanti, et al.
Nature Neuroscience (2020) Vol. 23, Iss. 6, pp. 771-781
Open Access | Times Cited: 382
Serotonin and neuroplasticity – Links between molecular, functional and structural pathophysiology in depression
Christoph Kraus, Eero Ċastrén, Siegfried Kasper, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 77, pp. 317-326
Closed Access | Times Cited: 380
Lower synaptic density is associated with depression severity and network alterations
Sophie Holmes, Dustin Scheinost, Sjoerd J. Finnema, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 378
Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial
Michael F. Grunebaum, Hanga Galfalvy, Tse‐Hwei Choo, et al.
American Journal of Psychiatry (2017) Vol. 175, Iss. 4, pp. 327-335
Open Access | Times Cited: 365
Ketamine: A Paradigm Shift for Depression Research and Treatment
John H. Krystal, Chadi G. Abdallah, Gerard Sanacora, et al.
Neuron (2019) Vol. 101, Iss. 5, pp. 774-778
Open Access | Times Cited: 357
The emerging role of exosomes in mental disorders
Saumeh Saeedi, Sonia Israel, Corina Nagy, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 335
Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions
Manoela V. Fogaça, Ronald S. Duman
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 310
Novel and emerging treatments for major depression
Steven Marwaha, Edward Palmer, Trisha Suppes, et al.
The Lancet (2022) Vol. 401, Iss. 10371, pp. 141-153
Open Access | Times Cited: 304
Page 1 - Next Page

Scroll to top